The availability of therapies to delay progression of type 1 diabetes provides opportunity for programs that track children with early stages of the disease, according to two speakers.
September 09, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
The advent of an immunotherapy to delay type 1 diabetes and more potential treatments in the pipeline have shifted the way health…
Youths who start using an automated insulin delivery system within 6 months of type 1 diabetes diagnosis are 82% more likely to…
Ketone monitoring is an essential part of type 1 diabetes management, and the availability of a dual glucose and ketone sensor…
NEW ORLEANS — Fewer than half of children and adolescents with type 2 diabetes are prescribed GLP-1 receptor agonists at most…
Patients with diabetes, especially type 1 diabetes or insulin-dependent type 2 diabetes, need regular access to care, and in…
Children and adults with type 1 diabetes who used a fast-acting mealtime insulin along with automated insulin delivery had…
